Research and Markets: Plague Therapeutics Pipeline Review 2015 - 8 Companies & 9 Drug Profiles

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/jxcp4b/plague_pipeline) has announced the addition of the "Plague - Pipeline Review, H1 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Plague, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Plague and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Companies Involved in Therapeutics Development

• Aradigm Corporation
• Cellceutix Corporation
• Grifols, S.A.
• iBio, Inc.
• Mucosis B.V.
• Summit Corporation plc
• Syntiron LLC
• Tetraphase Pharmaceuticals Inc.

Drug Profiles

• anthrax + plague vaccine
• ARD-3100
• ciprofloxacin hydrochloride
• PMX-30016
• pneumonic plaque vaccine
• Small Molecules to Inhibit Yoph Protein Tyrosine Phosphatase for Plague
• SMT-15000
• TP-271
• yersinia pestis vaccine

For more information visit http://www.researchandmarkets.com/research/jxcp4b/plague_pipeline